Biosimilars White Paper

Biosimilars White Paper  

Conducted just before the first biosimilar approval in the US, this white paper includes data on:

  • Familiarity with biosimilars
  • Knowledge of FDA guidance
  • Interest in prescribing biosimilars
  • Perceived challenges related to the use of biosimilars
  • …and more!

Download PDF

New & Noteworthy